Non-cardioselective beta-blocker + alpha-1 blocker
Carvedilol
Brand names: Eucardic
Adult dose
Dose: HF: start 3.125mg BD, double q2w to 25–50mg BD per tolerance; Hypertension: 12.5mg OD, increase to 25mg OD (max 50mg OD)
Route: Oral
Frequency: OD–BD with food
Clinical pearls
- NICE NG106 HF: prognostic beta-blocker (with bisoprolol, nebivolol)
- ESC HF: titrate to maximum tolerated dose
- Take with food to reduce orthostatic hypotension
Contraindications
- Severe asthma / COPD
- Decompensated heart failure (do not initiate)
- Severe bradycardia / heart block
- Cardiogenic shock
- Severe hepatic impairment
- Phaeochromocytoma (without alpha-block)
- Hypersensitivity
Side effects
- Hypotension (start low, go slow)
- Bradycardia
- Bronchospasm
- Fatigue
- Hypoglycaemia masking
- Erectile dysfunction
Interactions
- Verapamil/diltiazem (bradycardia)
- Insulin/oral hypoglycaemics
- Other antihypertensives
- Strong CYP2D6 inhibitors
Monitoring
- BP (sit/stand)
- HR
- Symptoms
- Renal function
- Weight (HF)
Reference: BNF; NICE NG106; ESC HF; https://bnf.nice.org.uk/drugs/carvedilol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- C-Peptide to Glucose Ratio · Diabetes Classification
- International Staging System (ISS) for Multiple Myeloma · Multiple Myeloma
- Revised ISS (R-ISS) for Multiple Myeloma · Haematological Malignancy
- International Staging System for Multiple Myeloma (ISS) · Oncology
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines